Department of Health Behavior and Health Education, University of Michigan School of Public Health, 109 South Observatory, Ann Arbor, MI 48109, USA.
J Health Commun. 2010;15 Suppl 3(0 3):92-101. doi: 10.1080/10810730.2010.525296.
The purpose of this study was (1) to examine the association of race/ethnicity on clinical trial awareness, controlling for several sociodemographic, attitudinal, and knowledge variables, and (2) to inform future communication campaigns to increase clinical trial awareness and participation. Secondary analysis was conducted among 6,754 Hispanic, Black, and White adult respondents to the National Cancer Institute's 2007 Health Information National Trends Survey (HINTS). The dependent variable was awareness of clinical trials. Logistic regression was used to examine possible correlates of clinical trial awareness including sociodemographics, trust of sources of health information, beliefs about safety of health information, family/personal history of cancer, health seeking information, and awareness of three health agencies. Compared with Whites, Blacks and Hispanics were significantly less likely to have heard of a clinical trial. Other significant correlates of clinical trial awareness included education, income, belief that health information is safely guarded, family history of cancer, awareness of the Centers for Disease control, trust of health information from the Internet and charitable organizations, and distrust of health information from religious institutions. Blacks and Hispanics are significantly less aware of clinical trials. Campaigns that exploit unique beliefs and delivery channels for racial/ethnic subgroups should be considered.
(1) 检验种族/民族与临床试验意识之间的关联,控制了多个社会人口统计学、态度和知识变量;(2) 为未来提高临床试验意识和参与度的传播活动提供信息。这项二次分析的对象是美国国家癌症研究所 2007 年健康信息国家趋势调查(HINTS)中 6754 名西班牙裔、黑人和白人成年受访者。因变量为对临床试验的认知。逻辑回归用于检验临床试验意识的可能相关因素,包括社会人口统计学、对健康信息来源的信任、对健康信息安全性的信念、癌症家族/个人史、健康信息寻求,以及对三个卫生机构的认知。与白人相比,黑人及西班牙裔人群听说过临床试验的可能性显著较低。其他与临床试验意识显著相关的因素包括教育程度、收入、对健康信息安全保护的信念、癌症家族史、对疾病控制中心的认知、对互联网和慈善机构健康信息的信任、以及对宗教机构健康信息的不信任。黑人及西班牙裔人群对临床试验的认知度显著较低。应考虑针对不同种族/民族亚群的独特信仰和传播渠道开展宣传活动。